Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Congenital bronchopulmonary malformations are a continuum of developmental anomalies of the bronchopulmonary unit for which classification, nomenclature, and management remain in evolution. Although their exact pathogenesis has not been fully elucidated, the frequently observed overlapping histologic features and recent advances in the field of molecular diagnosis suggest that these lesions share a common origin, and their differences may be the result of variations in timing of their development and/or location within the tracheobronchial tree. Improvements in prenatal imaging and increasing observational experience have resulted in a better understanding of the natural history of these anomalies, allowing an improved predictive capacity for pre-, peri-, and postnatal events. Finally, the postnatal management of these lesions has improved remarkably with advances in neonatal care and the development of the thoracoscopic approach. This chapter discusses the prenatal and postnatal management of the major congenital bronchopulmonary malformations, with an emphasis on the thoracoscopic approach for their resection.
Embryologic development of the human lung transitions through six separate stages to form a tracheobronchial tree with greater than 1 × 10 5 conducting and 1 × 10 7 respiratory airways. These stages include the embryonic, pseudoglandular, canalicular, saccular, alveolar, and microvascular stages. The progression of each stage is a highly coordinated process guided by mesenchymal–epithelial interactions under the influence of a number of regulatory growth factors. Briefly, the embryonic phase of lung development begins when the laryngotracheal bud arises from the anterior portion of the primitive aerodigestive tract. Beginning at week 5 in the pseudoglandular phase, the preacinar airways and blood vessels develop, followed by growth of the bronchial tree and development of all bronchial divisions by 16 weeks of gestation. The canalicular stage follows and is characterized by capillary growth toward the respiratory epithelium that marks the future blood–air interface. The transition to the saccular stage at 24 weeks is defined by widening of the peripheral air spaces distal to the terminal bronchioles with septa formation. The final stages of lung development include the alveolar stage, which is characterized by the formation of secondary septa and budding alveoli, and is followed by the microvascular stage with significant alveolar development and maturation. These last two stages continue throughout the first years of postnatal life. During this complex process, the development of congenital bronchopulmonary malformations (BPMs) and their pathogenesis can be related to specific time points in each of the six developmental stages ( Fig. 22.1 ).
Congenital BPMs represent 90% of all lung lesions seen in pediatric clinical practice and include congenital pulmonary airway malformations (CPAMs) (formerly called congenital cystic adenomatoid malformations [CCAMs]), intralobar bronchopulmonary sequestration (iBPS), extralobar bronchopulmonary sequestration (eBPS), congenital lobar emphysema (CLE), bronchial atresia (BA), and hybrid lesions (which contain features of CPAM and BPS). Less common malformations include bronchogenic cysts, lymphangiomas, and pleuropulmonary blastomas (PPBs), among others ( Box 22.1 ).
Bronchopulmonary malformation
Bronchogenic cyst
Bronchial atresia
Congenital pulmonary airway malformation (Stocker type 1 and 2)
Bronchopulmonary sequestration
Pulmonary hyperplasia and related lesions
Laryngeal atresia
Congenital pulmonary airway malformation (Stocker type 3)
Polyalveolar lobe
Congenital lobar emphysema
Other cystic lesions
Lymphatic/lymphangiomatous cysts
Enteric cysts
Mesothelial cysts
Simple parenchymal cysts
Low-grade cystic pleuropulmonary blastoma
Prenatal ultrasonography (US) is usually the first step in the prenatal evaluation of a congenital lung lesion. In addition, serial US exams are important to evaluate the prenatal behavior of the lesions, allowing planning of the pre-, peri-, and postnatal management on a case-by-case basis. We routinely perform fetal ultrafast magnetic resonance imaging (MRI) on all cases of prenatally diagnosed lung lesions to further define their anatomy, to evaluate the potential effects that the lesions can exert on surrounding structures, and to search for associated anomalies.
CPAMs are the most commonly diagnosed BPM. Prior to the appearance of reliable prenatal imaging, the incidence of CPAM in the general population was inaccurately calculated by the postnatal identification of symptomatic lesions later in life. Large series of pregnancies evaluated prenatally by US have recently shown a probable incidence of CPAM of about 1.5 cases per 10,000 live births. This heterogeneous group of congenital cystic and noncystic lung masses is characterized by an overgrowth of immature primary bronchioles localized at a particular segment of the bronchial tree ( Fig. 22.2 ). The current classification system divides CPAMs into five types that differ by location, cystic structure, size, and epithelial lining ( Table 22.1 ). However, from a practical perspective, CPAMs can be divided into two categories based on prenatal US findings: (1) macrocystic lesions containing a dominant cyst or multiple cysts that are ≥5.0 mm in diameter and (2) microcystic lesions presenting as a solid echogenic mass ( Fig. 22.3 ).
Type | Incidence | Single/Multiple Cysts | Size of Cysts | Lining of Cysts |
---|---|---|---|---|
0 | <2% | Multiple | Variable | Pseudostratified ciliated columnar epithelium |
1 | 60–70% | Single or Multiple | >2 cm | Cilated pseudostratified columnar epithelium |
2 | 15–20% | Multiple | <1 cm | Cilated cuboidal or columnar epithelium |
3 | 5–10% | Solid or Multiple scattered thin-walled cysts | <2 cm | Low cuboidal epithelium |
4 | 10% | Single or Multiple | Variable | Type 1 and 2 alveolar cells |
On prenatal US, early in gestation CPAMs appear as hyperechogenic areas, with or without hypoechoic cysts, that vary in number and size. Large lesions can cause a mass effect on surrounding structures. This is seen on US images as mediastinal shift, diaphragmatic eversion, and, in the most severe cases, hydrops fetalis (e.g., polyhydramnios, ascites, pleural effusions). Pure CPAMs receive their vascular supply from the pulmonary artery and have pulmonary venous drainage. However, there is a subset of CPAMs that receive additional blood supply from a single or multiple systemic feeding vessels, which is usually considered one of the distinctive features of BPS. The systemic vessels can be one or more, and are generally branches of the abdominal aorta ( Fig. 22.4 ). CPAMs that have this feature are called hybrid lesions because of the overlapping features of CPAM and BPS. Even though the diagnosis of a CPAM by an experienced sonographer is usually straightforward, sometimes there can be confusion with other conditions ( Table 22.2 ). A skilled sonographer can usually differentiate these other lesions by understanding the blood supply (congenital diaphragmatic hernia [CDH], lung agenesis, BPS), by detecting bowel peristalsis (CDH), by documenting the absence of one lung (lung agenesis), or by detecting bronchial dilation (bronchial atresia, congenital high airway obstruction syndrome [CHAOS]).
Anomaly | Misdiagnosis |
---|---|
Right-sided congenital diaphragmatic hernia; Lung agenesis | Large right-sided microcystic CPAM: similar echogenicity of liver to microcystic CPAM |
Large microcystic CPAM: appearance of mediastinal shift with a large echogenic lung | |
Congenital high airway obstruction syndrome; Mainstem bronchial, lobar, or segmental atresia | Bilateral large microcystic CPAM: bilateral large echogenic lungs with diaphragmatic eversion |
Microcystic CPAM: hyperplasia of distal lung and increased echogenicity |
BPS comprise approximately 10% of prenatally diagnosed BPMs and are defined as a portion of lung parenchyma that does not communicate with the normal tracheobronchial tree. These lesions have a systemic arterial blood supply and may have systemic and/or pulmonary venous return. Two different types of sequestration are described: intralobar (iBPS) and extralobar (eBPS), which differ in their prenatal and postnatal characteristics. iBPS share the visceral pleural investment with the normal adjacent lung and have their venous return to the pulmonary veins. In contrast, eBPSs have a separate pleural investment and may have systemic and/or pulmonary venous drainage.
EBPSs are seen as a homogeneous hyperechoic mass in a paraspinal location most often in the left lower thorax, although they can be right-sided, mid or upper thoracic, and even intra-abdominal ( Fig. 22.5 ). The pathogenesis is related to a supernumerary lobe developing from abnormal budding early in foregut embryogenesis. If the bud arises before the development of the pleura, it is invested with the adjacent lung and becomes an iBPS. If the bud develops after visceral pleural formation, it grows separately and turns into an eBPS. EBPSs can contain CPAM components on histology ( Fig. 22.6 ). In contrast to eBPSs, iBPS have pulmonary venous drainage and are uniformly associated with the lower lobes. They are distinguishable from hybrid lesions by the absence of cysts and the presence of pulmonary arterial inflow in addition to their systemic arterial inflow. Prenatally, careful Doppler US identification of the arterial inflow to these lesions is required to distinguish between a microcystic hybrid CPAM and an iBPS. Postnatal contrast-enhanced computed tomography (CT) should be obtained in all patients to confirm the anatomy and to aid in the management. The final diagnosis will depend on histologic analysis and is frequently a combination of the classifications previously described.
CLE is a condition characterized by overinflation and distension of one or more pulmonary lobes secondary to a one-way-valve mechanism, with variable degrees of compression of the adjacent lung ( Fig. 22.7 ). In half the cases, the cause is unknown. In the remaining half, the overdistention results from dysplastic and weakened bronchial cartilage; endobronchial obstruction; extrinsic compression from vascular structures, cysts, tumors, etc.; or diffuse bronchial abnormalities related to infection. In the fetus, amniotic fluid trapping is analogous to postnatal air trapping, and can lead to lobar expansion. The left upper lobe is the most frequently affected, followed by right middle and upper lobes, with rare bilateral or multifocal involvement. Most neonates/infants present with respiratory distress.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here